The development and implementation of a TMT-SRM assay for the validation of candidate biomarkers of Alzheimer's disease
Biomarker discovery studies in plasma have revealed several proteins which may have clinical utility in the diagnosis and prognosis of Alzheimer’s disease. The qualification of these proteins as true biomarkers, sensitive and specific to the disease, requires rapid, high quality, quantitative assays...
Main Author: | |
---|---|
Published: |
King's College London (University of London)
2011
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.628031 |